soul trial oral semaglutide cardiovascular outcomes results 2024 2025 (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine soul trial oral semaglutide cardiovascular

We provide a full range of services to help patients achieve and maintain their health goals

However, using GLP-1 agonists for minor weight loss or body sculpting when one is already at a healthy weight is not only medically inappropriate but also carries significant health risks without the offsetting medical benefits

The term folate should be used to refer only to the bioactive forms of folic acid, namely dihydrofolate (DHF) and tetrahydrofolate (THF) and their derivatives

Detailed Guide on Vitamin C Serum 3

All other data supporting the findings of this study are available from the corresponding authors on reasonable request

Research and expert guidance consistently emphasize that preserving muscle during weight loss supports strength, recovery, and long-term health